Gout Therapeutic Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Gout Therapeutic Market to 2027 - Global Analysis and Forecasts By Drugs (NSAIDs, Corticosteroids, Colchicine, Urate-Lowering Agents); Application (Acute, Chronic)

Report Code: TIPRE00005213 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Gout is a complicated form of inflammatory arthritis identified by frequent attacks of a severe pain and swollen joints. It is basically characterized by a defective metabolism of uric acid that causes arthritis especially in the smaller bones of the feet, deposition of chalk stones and episodes of acute pain.

MARKET DYNAMICS
The Gout Therapeutic market is anticipated to grow in the forecast, owing to the factors such as growing drug pipeline, easy availability, changing lifestyle, increasing alcohol consumption, high purine diet, rising obesity and kidney diseases, consumption of medicines such as diuretics, rise in demand for biologics for treatment of gout across the globe and novel launches of drugs. Low levels of physician and low patient awareness are expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Gout Therapeutic Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gout Therapeutic market with detailed market segmentation by Drugs, Application and geography. The global Gout Therapeutic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Gout Therapeutic market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Gout Therapeutic market is segmented on the basis of Drugs and Application. Based on Drugs the market is segmented into NSAIDs, Corticosteroids, Colchicine, Urate-Lowering Agents. Based on Application the market is segmented into Acute, Chronic.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gout Therapeutic market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gout Therapeutic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Gout Therapeutic market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Gout Therapeutic market in these regions.

MARKET PLAYERS
The reports cover key developments in the Gout Therapeutic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Gout Therapeutic market are anticipated to lucrative growth opportunities in the future with the rising demand for Gout Therapeutic market in the global market. Below mentioned is the list of few companies engaged in the Gout Therapeutic market.

The report also includes the profiles of Gout Therapeutic market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • ALDER BIOPHARMACEUTICALS, INC
  • Eli Lilly and Company
  • Antares Pharma
  • Humanigen, Inc
  • Astellas Pharma Inc
  • Mayo Foundation for Medical Education and Research
  • AstraZeneca
  • Cigna
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gout Therapeutic Market - By Drugs
1.3.2 Gout Therapeutic Market - By Application
1.3.3 Gout Therapeutic Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GOUT THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GOUT THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GOUT THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. GOUT THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. GOUT THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GOUT THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. NSAIDS
7.3.1. Overview
7.3.2. NSAIDs Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.5. COLCHICINE
7.5.1. Overview
7.5.2. Colchicine Market Forecast and Analysis
7.6. URATE-LOWERING AGENTS
7.6.1. Overview
7.6.2. Urate-Lowering Agents Market Forecast and Analysis
8. GOUT THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ACUTE
8.3.1. Overview
8.3.2. Acute Market Forecast and Analysis
8.4. CHRONIC
8.4.1. Overview
8.4.2. Chronic Market Forecast and Analysis
9. GOUT THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gout Therapeutic Market Overview
9.1.2 North America Gout Therapeutic Market Forecasts and Analysis
9.1.3 North America Gout Therapeutic Market Forecasts and Analysis - By Drugs
9.1.4 North America Gout Therapeutic Market Forecasts and Analysis - By Application
9.1.5 North America Gout Therapeutic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gout Therapeutic Market
9.1.5.1.1 United States Gout Therapeutic Market by Drugs
9.1.5.1.2 United States Gout Therapeutic Market by Application
9.1.5.2 Canada Gout Therapeutic Market
9.1.5.2.1 Canada Gout Therapeutic Market by Drugs
9.1.5.2.2 Canada Gout Therapeutic Market by Application
9.1.5.3 Mexico Gout Therapeutic Market
9.1.5.3.1 Mexico Gout Therapeutic Market by Drugs
9.1.5.3.2 Mexico Gout Therapeutic Market by Application
9.2. EUROPE
9.2.1 Europe Gout Therapeutic Market Overview
9.2.2 Europe Gout Therapeutic Market Forecasts and Analysis
9.2.3 Europe Gout Therapeutic Market Forecasts and Analysis - By Drugs
9.2.4 Europe Gout Therapeutic Market Forecasts and Analysis - By Application
9.2.5 Europe Gout Therapeutic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gout Therapeutic Market
9.2.5.1.1 Germany Gout Therapeutic Market by Drugs
9.2.5.1.2 Germany Gout Therapeutic Market by Application
9.2.5.2 France Gout Therapeutic Market
9.2.5.2.1 France Gout Therapeutic Market by Drugs
9.2.5.2.2 France Gout Therapeutic Market by Application
9.2.5.3 Italy Gout Therapeutic Market
9.2.5.3.1 Italy Gout Therapeutic Market by Drugs
9.2.5.3.2 Italy Gout Therapeutic Market by Application
9.2.5.4 Spain Gout Therapeutic Market
9.2.5.4.1 Spain Gout Therapeutic Market by Drugs
9.2.5.4.2 Spain Gout Therapeutic Market by Application
9.2.5.5 United Kingdom Gout Therapeutic Market
9.2.5.5.1 United Kingdom Gout Therapeutic Market by Drugs
9.2.5.5.2 United Kingdom Gout Therapeutic Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gout Therapeutic Market Overview
9.3.2 Asia-Pacific Gout Therapeutic Market Forecasts and Analysis
9.3.3 Asia-Pacific Gout Therapeutic Market Forecasts and Analysis - By Drugs
9.3.4 Asia-Pacific Gout Therapeutic Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Gout Therapeutic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gout Therapeutic Market
9.3.5.1.1 Australia Gout Therapeutic Market by Drugs
9.3.5.1.2 Australia Gout Therapeutic Market by Application
9.3.5.2 China Gout Therapeutic Market
9.3.5.2.1 China Gout Therapeutic Market by Drugs
9.3.5.2.2 China Gout Therapeutic Market by Application
9.3.5.3 India Gout Therapeutic Market
9.3.5.3.1 India Gout Therapeutic Market by Drugs
9.3.5.3.2 India Gout Therapeutic Market by Application
9.3.5.4 Japan Gout Therapeutic Market
9.3.5.4.1 Japan Gout Therapeutic Market by Drugs
9.3.5.4.2 Japan Gout Therapeutic Market by Application
9.3.5.5 South Korea Gout Therapeutic Market
9.3.5.5.1 South Korea Gout Therapeutic Market by Drugs
9.3.5.5.2 South Korea Gout Therapeutic Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gout Therapeutic Market Overview
9.4.2 Middle East and Africa Gout Therapeutic Market Forecasts and Analysis
9.4.3 Middle East and Africa Gout Therapeutic Market Forecasts and Analysis - By Drugs
9.4.4 Middle East and Africa Gout Therapeutic Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Gout Therapeutic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gout Therapeutic Market
9.4.5.1.1 South Africa Gout Therapeutic Market by Drugs
9.4.5.1.2 South Africa Gout Therapeutic Market by Application
9.4.5.2 Saudi Arabia Gout Therapeutic Market
9.4.5.2.1 Saudi Arabia Gout Therapeutic Market by Drugs
9.4.5.2.2 Saudi Arabia Gout Therapeutic Market by Application
9.4.5.3 U.A.E Gout Therapeutic Market
9.4.5.3.1 U.A.E Gout Therapeutic Market by Drugs
9.4.5.3.2 U.A.E Gout Therapeutic Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gout Therapeutic Market Overview
9.5.2 South and Central America Gout Therapeutic Market Forecasts and Analysis
9.5.3 South and Central America Gout Therapeutic Market Forecasts and Analysis - By Drugs
9.5.4 South and Central America Gout Therapeutic Market Forecasts and Analysis - By Application
9.5.5 South and Central America Gout Therapeutic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gout Therapeutic Market
9.5.5.1.1 Brazil Gout Therapeutic Market by Drugs
9.5.5.1.2 Brazil Gout Therapeutic Market by Application
9.5.5.2 Argentina Gout Therapeutic Market
9.5.5.2.1 Argentina Gout Therapeutic Market by Drugs
9.5.5.2.2 Argentina Gout Therapeutic Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. GOUT THERAPEUTIC MARKET, KEY COMPANY PROFILES
11.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALDER BIOPHARMACEUTICALS, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ANTARES PHARMA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. HUMANIGEN, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ASTELLAS PHARMA INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ASTRAZENECA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CIGNA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Boehringer Ingelheim International GmbH
- GlaxoSmithKline plc
- ALDER BIOPHARMACEUTICALS, INC
- Eli Lilly and Company
- Antares Pharma
- Humanigen, Inc
- Astellas Pharma Inc
- Mayo Foundation for Medical Education and Research
- AstraZeneca
- Cigna
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book